Afatinib and Gemcitabine/Nab-paclitaxel in Metastatic Pancreatic Cancer

Clinical trial NCT02975141 · UNKNOWN

Trial details

NCT number: NCT02975141
Sponsor: PD Dr. med. Volker Heinemann
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Pancreatic Cancer

Start date: 2016-09-01
Primary completion: 2018-12-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.